Checkpoint Therapeutics, Inc.
(NASDAQ : CKPT)

( )
CKPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.05%41.940.9%$954.26m
JNJJohnson & Johnson
0.04%138.890.7%$780.65m
MRKMerck & Co., Inc.
0.22%81.200.6%$745.47m
BMYBristol-Myers Squibb Company
-0.99%46.831.4%$627.82m
LLYEli Lilly and Company
0.04%116.861.0%$478.55m
ABBVAbbVie, Inc.
-1.32%80.082.2%$408.18m
AZNAstraZeneca PLC Sponsored ADR
0.96%39.031.3%$191.83m
NVSNovartis AG Sponsored ADR
3.62%87.500.2%$171.58m
GSKGlaxoSmithKline plc Sponsored ADR
0.48%40.180.2%$97.11m
NVONovo Nordisk A/S Sponsored ADR Class B
0.43%48.590.1%$65.75m
SNYSanofi Sponsored ADR
0.40%42.280.2%$49.55m
LCILannett Company, Inc.
-7.14%5.6636.7%$9.52m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.14%2.291.6%$0.41m
EPIXESSA Pharma Inc
21.95%2.500.1%$0.02m

Company Profile

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.